Infectious Disease Control

CGTN: China protects lives, shares experience in global COVID-19 fight

BEIJING, Jan. 16, 2023 /PRNewswire/ -- Chinese people are embracing a bustling winter after the country downgraded its COVID-19 management policies.  It's a breakthrough in the country's three-year fight against the pandemic, but challenges still lie ahead.  Along the journey, China went all out...

2023-01-16 07:29 2077

CGTN: TCM continues to play significant role in treating COVID-19

BEIJING, Jan. 11, 2023 /PRNewswire/ -- Traditional Chinese Medicine (TCM) has been playing an important role inChina's fight against COVID-19.  As China is shifting the focus of its COVID-19 response from preventing infections to protecting people's health and preventing severe cases, the unique...

2023-01-11 23:09 3111

CGTN: China downgrades COVID-19 rules as nation readies for normal life

BEIJING, Jan. 9, 2023 /PRNewswire/ -- China put its downgraded COVID-19 measures into force on Sunday as the nation began to resume normal life after three years of strict pandemic management. The nation reopened its border p...

2023-01-09 10:42 2453

China welcomes first arrivals following downgraded COVID management

BEIJING, Jan. 9, 2023 /PRNewswire/ -- A report from People's Daily: The first flights underChina's new COVID-19 management for international travelers arrived at airports in southChina's Guangdong province on Jan. 8, according to the national customs authority. Over 380 passengers were aboard tw...

2023-01-09 07:40 2047

CGTN: China's preparedness for adjusting its COVID-19 policies

BEIJING, Jan. 5, 2023 /PRNewswire/ -- Since China prioritized its COVID-19 response from the dynamic zero-COVID policy, some Western media and intellectuals have been questioningChina's "preparedness" of making the change. Preparedness can ...

2023-01-05 04:07 1657

CGTN: China's dynamic zero-COVID policy sets the foundation for reopening

BEIJING, Jan. 5, 2023 /PRNewswire/ -- China has adjusted its response to COVID-19 prevention and control in recent weeks. It announced it will downgrade COVID-19 management from Class A to Class B infectious disease while resuming passport, visa issuance and easing border-entry policies starting ...

2023-01-05 04:05 1997

China's optimization of control measures lays solid foundation for COVID-19 response

BEIJING, Jan. 4, 2023 /PRNewswire/ -- A report from People's Daily: Local authorities and relevant departments inChina have been making unremitting efforts recently to ensure the supply of medical resources, satisfy the demand for medicines and focus on the prevention and treatment of high-risk g...

2023-01-04 15:39 2137

Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company

--Focus on renal disease and mRNA platform portfolios-- --Build out commercialization capabilities in preparation for the potential approval and launch of Nefecon and Xerava inChina in 2023-- --Leverage both in-house discovery and strategic business development to establish industry leadership ...

2023-01-03 16:00 2991

CGTN: China monitors coronavirus mutations to adjust COVID-19 response

BEIJING, Jan. 3, 2023 /PRNewswire/ -- With China loosening its COVID-19 restrictions, some experts have expressed concern thatChina's relaxation of COVID-19 limitations will enhance the likelihood of the virus mutating. "It is a worry," said CNN, citing William Schaffner, professor at the Divisi...

2023-01-03 08:27 1436

CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address

BEIJING, Jan. 1, 2023 /PRNewswire/ -- From medical professionals to delivery men and women, from community workers to next-door neighbors, ordinary Chinese people are doing their best and lending a hand to help others cope with the latest waves of COVID-19 infections in the country. &amp...

2023-01-03 07:52 1330

CGTN:How do emergency wards in China cope with increasing COVID patients?

BEIJING, Jan. 3, 2023 /PRNewswire/ -- Ninety-year-old Qu Fucheng was waiting for his COVID-19 treatment in Wuhan Zhongnan Hospital when his son realized how crowded the emergency department was. "My father was in very critical ...

2023-01-03 06:54 1345

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

GAITHERSBURG, Md., Dec. 31, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the initiation of a Phase 2 trial for its COVID-19-Influenza Combination (CI...

2022-12-30 21:00 3862

Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19

* GS221 has conducted 3 clinical trials. Current results of clinical trials show favorable safety and tolerance in the subjects. After administration, the patients showed trends of improvement of clinical symptoms, shortening time for negative nucleic acid test, and rapid decline of viral load;...

2022-12-30 13:23 2926

CGTN: Vitality under COVID-19: China's smart ports aid increased throughput

BEIJING, Dec. 29, 2022 /PRNewswire/ -- China's Qingdao Port, a subsidiary of Shandong Port Group and the second-largest foreign trade port in eastChina's Shandong Province, has seen an increase in anchorage rotations of very large container ships, according to China Media Group. The port has han...

2022-12-29 11:55 6898

CGTN: Vitality under COVID-19: China gears up for medical supplies

BEIJING, Dec. 28, 2022 /PRNewswire/ -- China has made efforts to ensure the medical supplies needed for COVID-19 prevention and control after it loosened its epidemic measures in early December, which was followed by an increase in infections and surging demand for medicines. The country's Natio...

2022-12-28 00:13 6648

Brii Biosciences Provides Update on Strategic Clinical Development Progress

Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023 Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical hol...

2022-12-27 20:00 2728

China to downgrade COVID-19 management to Class B

BEIJING, Dec. 27, 2022 /PRNewswire/ -- A report from People's Daily: China will downgrade management of COVID-19 to Class B and cancel quarantine requirements on inbound travelers fromJan. 8, 2023, China's top health authority announced recently. In a statement released late Monday, the National...

2022-12-27 18:06 2240

Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification

* Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets * With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India HYDERABAD, India, Dec. 27, ...

2022-12-27 10:00 3342

China actively optimizes COVID-19 response measures to better prepare for challenges

BEIJING, Dec. 26, 2022 /PRNewswire/ -- As multiple regions in China have seen surging COVID-19 infections, local governments are taking swift and precise measures to prevent severe cases, protect people's health, and build a barrier against the epidemic. These measures include providing timely m...

2022-12-26 14:32 3123

CGTN: 'New Approaches': How China stepped up its COVID-19 treatments

BEIJING, Dec. 21, 2022 /PRNewswire/ -- China has been racing against the clock in developing COVID-19 drugs while promoting vaccination – one for saving lives and the other for providing broad protection. While the stringent COVID-19 containment measures of the past three years helpedChina evade...

2022-12-21 18:51 2169
12345678 ... 65

Week's Top Stories